2012 annual financial data
Fate Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -497.15%.
Operating income was -13,557,000 USD and net income was -14,239,000 USD.
Operating cash flow was -13,274,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,670,000 USD
- Operating income
- -13,557,000 USD
- Net income
- -14,239,000 USD
- Operating cash flow
- -13,274,000 USD